According to a newly published market research report by 24LifeSciences, global stem cell therapy for diabetes and related conditions market was valued at USD 456 million in 2024 and is projected to reach USD 892 million by 2031, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 2025–2031. Stem cell therapy...